Drug Shortage Report for BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Report ID | 225238 |
Drug Identification Number | 02496852 |
Brand name | BENDAMUSTINE HYDROCHLORIDE FOR INJECTION |
Common or Proper name | BENDAMUSTINE HYDROCHLORIDE |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | BENDAMUSTINE HYDROCHLORIDE |
Strength(s) | 25MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 25ML |
ATC code | L01AA |
ATC description | ALKYLATINGAGENTS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2024-07-15 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2024-04-16 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2024-04-16 | English | Compare |
v2 | 2024-04-16 | French | Compare |
Showing 1 to 2 of 2